规格: | 5mg | 产品价格: | 340 |
---|
规格: | 20mg | 产品价格: | 750 |
---|
规格: | 50mg | 产品价格: | 1040 |
---|
规格: | 100mg | 产品价格: | 1820 |
---|
Catalog Number GC13396
Synonyms CAL-101,CAL101,Idelalisib,GS-1101,GS1101
Molecular Formula C22H18FN7O
Relative Molecular Mass 415.43
CAS Registry Number 870281-82-6
Formulation A solid
Purity ≥98%
Storage Store at -20°C
SMILES CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5
产品描述
CAL-101 (Idelalisib, GS-1101), is a p110δ selective phosphatidylinositol-3-kinase inhibitor in a kinome-wide screen using purified enzymes and in cell-based PI3K isoform-specific assays. Phosphatidylinositol-3-kinase p110δ serves as a central integration point for signaling from cell surface receptors known to promote malignant B-cell proliferation and survival. CAL-101 can block constitutive phosphatidylinositol-3-kinase signaling, resulting in reduced phosphorylation of Akt and other downstream effect factors, an increase in poly(ADP-ribose) polymerase and caspase cleavage and an induction of apoptosis. These effects have been observed across a broad range of immature and mature B-cell malignancies. In addition, CAL-101 abrogated protection from spontaneous apoptosis induced by B cell–activating factors CD40L, TNF-α, and fibronectin.ReferenceBrian J. Lannutti, Sarah A. Meadows, Sarah E. M. Herman, Adam Kashishian, Bart Steiner, Amy J. Johnson, John C. Byrd, Jeffrey W. Tyner, Marc M. Loriaux, Mike Deininger, Brian J. Druker, Kamal D. Puri, Roger G. Ulrich, and Neill A. Giese. CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood. 2011; 117(2): 591 – 594.Sarah E. M. Herman, Amber L. Gordon, Amy J. Wagner, Nyla A. Heerema, Weiqiang Zhao, Joseph M. Flynn, Jeffrey Jones, Leslie Andritsos, Kamal D. Puri, Brian J. Lannutti, Neill A. Giese, Xiaoli Zhang, Lai Wei, John C. Byrd, Amy J. Johnson. Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals. Blood. 2010; 116(12): 2078 – 88.
更多产品信息,请点击:https://www.glpbio.cn/search.php?catalog=GC13396原装进口,CAL-101 (Idelalisib, GS-1101),美国GlpBio品Pai大包装更优惠!
美国Glpbio是一家领先的小分子YZ剂、激活剂、化合物库、多肽和实验室试剂的供应商。公司经营范围广泛,产品涉及癌症、免疫学、神经科学、细胞凋亡、表观遗传学等20多个不同研究领域,拥有10000多种产品。总部位于美国加利福尼亚,营销网点遍及法国、德国、加拿大、日本、澳大利亚、新加坡、以色列等20多个国家地区,竭诚为各国的科研工作者提供优质的产品和专业的服务。
温馨提示:不可用于临床ZL。